Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies

Despite decades of research and successful improvements in diagnosis and therapy, prostate cancer (PC) remains a major challenge. In recent years, it has become clear that PC stem cells (PCSCs) are the driving force in tumorigenesis, relapse, metastasis, and therapeutic resistance of PC. In this min...

Full description

Bibliographic Details
Main Authors: Isis Wolf, Christian Gratzke, Philipp Wolf
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.935715/full
_version_ 1817976988403499008
author Isis Wolf
Isis Wolf
Christian Gratzke
Christian Gratzke
Philipp Wolf
Philipp Wolf
author_facet Isis Wolf
Isis Wolf
Christian Gratzke
Christian Gratzke
Philipp Wolf
Philipp Wolf
author_sort Isis Wolf
collection DOAJ
description Despite decades of research and successful improvements in diagnosis and therapy, prostate cancer (PC) remains a major challenge. In recent years, it has become clear that PC stem cells (PCSCs) are the driving force in tumorigenesis, relapse, metastasis, and therapeutic resistance of PC. In this minireview, we discuss the impact of PCSCs in the clinical practice. Moreover, new therapeutic approaches to combat PCSCs are presented with the aim to achieve an improved outcome for patients with PC.
first_indexed 2024-04-13T22:10:15Z
format Article
id doaj.art-9b15ab24df6341d097dbfce5775b1bff
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-13T22:10:15Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-9b15ab24df6341d097dbfce5775b1bff2022-12-22T02:27:46ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-07-011210.3389/fonc.2022.935715935715Prostate Cancer Stem Cells: Clinical Aspects and Targeted TherapiesIsis Wolf0Isis Wolf1Christian Gratzke2Christian Gratzke3Philipp Wolf4Philipp Wolf5Department of Urology, Medical Center-University of Freiburg, Freiburg, GermanyFaculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Urology, Medical Center-University of Freiburg, Freiburg, GermanyFaculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Urology, Medical Center-University of Freiburg, Freiburg, GermanyFaculty of Medicine, University of Freiburg, Freiburg, GermanyDespite decades of research and successful improvements in diagnosis and therapy, prostate cancer (PC) remains a major challenge. In recent years, it has become clear that PC stem cells (PCSCs) are the driving force in tumorigenesis, relapse, metastasis, and therapeutic resistance of PC. In this minireview, we discuss the impact of PCSCs in the clinical practice. Moreover, new therapeutic approaches to combat PCSCs are presented with the aim to achieve an improved outcome for patients with PC.https://www.frontiersin.org/articles/10.3389/fonc.2022.935715/fullprostate cancerprostate cancer stem cellsprostate cancer stem cell hypothesisprostate cancer stem cell antigensprostate cancer stem cell therapy
spellingShingle Isis Wolf
Isis Wolf
Christian Gratzke
Christian Gratzke
Philipp Wolf
Philipp Wolf
Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies
Frontiers in Oncology
prostate cancer
prostate cancer stem cells
prostate cancer stem cell hypothesis
prostate cancer stem cell antigens
prostate cancer stem cell therapy
title Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies
title_full Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies
title_fullStr Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies
title_full_unstemmed Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies
title_short Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies
title_sort prostate cancer stem cells clinical aspects and targeted therapies
topic prostate cancer
prostate cancer stem cells
prostate cancer stem cell hypothesis
prostate cancer stem cell antigens
prostate cancer stem cell therapy
url https://www.frontiersin.org/articles/10.3389/fonc.2022.935715/full
work_keys_str_mv AT isiswolf prostatecancerstemcellsclinicalaspectsandtargetedtherapies
AT isiswolf prostatecancerstemcellsclinicalaspectsandtargetedtherapies
AT christiangratzke prostatecancerstemcellsclinicalaspectsandtargetedtherapies
AT christiangratzke prostatecancerstemcellsclinicalaspectsandtargetedtherapies
AT philippwolf prostatecancerstemcellsclinicalaspectsandtargetedtherapies
AT philippwolf prostatecancerstemcellsclinicalaspectsandtargetedtherapies